Effect of potassium channel blocker 4-aminopyridine pretreatment on the 6-OHDA-induced Parkinson's disease in rats

Effect of potassium channel blocker 4-aminopyridine pretreatment on the 6-OHDA-induced Parkinson's disease in rats

Background: Nuclease and caspase enzymes activities which promote death signals and lead to apoptosis are dependent to potassium ions. Objective: The aim of this study was to determine the effect of 4-aminopyridine (4-AP) potassium channel blocker on the animal model of Parkinson's disease. M...

Full description

Bibliographic Details
Main Authors:	M. Sofiabadi, H. Haghdoost-Yazdi, M. Mahmudi, H. Piri, T. Dargahi, M. Yaghubidust
Format:	Article
Language:	fas
Published:	Qazvin University of Medical Sciences & Health Services 2015-06-01
Series:	The Journal of Qazvin University of Medical Sciences
Subjects:	Potassium Channel Blockers Oxidopamine Parkinson Disease Substantia Nigra
Online Access:	http://journal.qums.ac.ir/browse.php?a_id=1814&slc_lang=en&sid=1&ftxt=1

Similar Items

Effect of potassium channel blocker Tetraethylammonium pretreatment on prevention of the 6-OHDA-induced chronic Parkinson's disease in rats
by: H. Haghdoost-Yazdi, et al.
Published: (2016-06-01)

Long-term Levodopa Treatment Accelerates the Circadian Rhythm Dysfunction in a 6-hydroxydopamine Rat Model of Parkinson's Disease
by: Si-Yue Li, et al.
Published: (2017-01-01)

Substantia Nigra Hyperechogenicity Reflects the Progression of Dopaminergic Neurodegeneration in 6-OHDA Rat Model of Parkinson’s Disease
by: Siyan Zhang, et al.
Published: (2020-08-01)

Changes of neurons and blood vessels of human substantia nigra in aging: Morphometric study
by: Krivokuća Zdenka, et al.
Published: (2017-01-01)

Role of Potassium-Competitive Acid Blockers in Helicobacter pylori Eradication
by: Jong Kyu Park
Published: (2017-03-01)

Hematological disorders in 6-hydroxydopamine-induced rat model of Parkinson’s disease
by: Lucian Hritcu
Published: (2008-09-01)

The Construction and Validation of a Novel Ferroptosis-Related Gene Signature in Parkinson’s Disease
by: Tingting Liu, et al.
Published: (2023-12-01)

The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson's disease
by: E. Ilijic, et al.
Published: (2011-08-01)

An early axonopathy in a hLRRK2(R1441G) transgenic model of Parkinson disease
by: Patricia Tagliaferro, et al.
Published: (2015-10-01)

Increased Serum Lithium Level due to Mild to Moderate damage to Dopaminergic Neurons of the Substantia Nigra, Evidence from Animal Model of Parkinson’s Disease induced by 6-Hydoxydopamine
by: Mohammad Hossein Esmaeili, et al.
Published: (2022-12-01)

Enhanced sensitivity of DJ-1-deficient dopaminergic neurons to energy metabolism impairment: Role of Na+/K+ ATPase
by: A. Pisani, et al.
Published: (2006-07-01)

Gait Analysis for Early Detection of Motor Symptoms in the 6-OHDA Rat Model of Parkinson's Disease
by: Jordi Boix, et al.
Published: (2018-03-01)

Dopamine depletion in wistar rats with epilepsy
by: E. M. Trindade-Filho, et al.
Published: (2022-05-01)

Dietary and Intraperitoneal Administration of Selenium Provide Comparable Protection in the 6-Hydroxydopamine Lesion Rat Model of Parkinson's Disease
by: Cecilia M. Fox, et al.
Published: (2007-01-01)

Optimal Use of Proton Pump Inhibitors and Potassium-competitive Acid Blockers
by: Jong Kyu Park
Published: (2023-09-01)

The Neuro-Protective Effects of the TSPO Ligands CB86 and CB204 on 6-OHDA-Induced PC12 Cell Death as an In Vitro Model for Parkinson’s Disease
by: Sheelu Monga, et al.
Published: (2021-11-01)

Time dependent degeneration of the nigrostriatal tract in mice with 6-OHDA lesioned medial forebrain bundle and the effect of activin A on l-Dopa induced dyskinesia
by: Peggy Rentsch, et al.
Published: (2019-02-01)

Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: Diminished compensatory mechanisms as a prelude to parkinsonism
by: Timothy J. Collier, et al.
Published: (2007-04-01)

Height and nigral neuron density in Parkinson’s disease
by: Laura Saari, et al.
Published: (2022-07-01)

Peripheral inflammation and neuroprotection: Systemic pretreatment with complete Freund's adjuvant reduces 6-hydroxydopamine toxicity in a rodent model of Parkinson's disease
by: Marie-Thérèse Armentero, et al.
Published: (2006-12-01)

MRI Findings in Parkinson’s Disease: Radiologic Assessment of Nigrostriatal Degeneration
by: Yun Jung Bae, et al.
Published: (2022-05-01)

Revealing a novel contributing landscape of ferroptosis-related genes in Parkinson’s disease
by: Xingxing Jian, et al.
Published: (2022-01-01)

Environmental Risk Factors and Parkinson's Disease: Selective Degeneration of Nigral Dopaminergic Neurons Caused by the Herbicide Paraquat
by: Alison L. McCormack, et al.
Published: (2002-07-01)

Non-linear developmental trajectory of electrical phenotype in rat substantia nigra pars compacta dopaminergic neurons
by: Martial A Dufour, et al.
Published: (2014-10-01)

INTERACTION OF VESICULAR MONOAMINE TRANSPORTER 2 (VMAT2) AND NEUROMELANIN PIGMENT AMONG THE MIDBRAIN DOPAMINERGIC NEURONS, IN MAN
by: P. Pasbakhsh, et al.
Published: (2004-05-01)

The application value of quantitative susceptibility mapping in evaluating substantia nigra "swallow tail sign" in the diagnosis of Parkinson's disease
by: Xiao-jun GUAN, et al.
Published: (2018-04-01)

Pretreatment with Human Lactoferrin Had a Positive Effect on the Dynamics of Mouse Nigrostriatal System Recovery after Acute MPTP Exposure
by: Marina Yu. Kopaeva, et al.
Published: (2021-01-01)

Application and progress of transcranial substantial ultrasound in Parkinson's disease
by: Xishun Ma, et al.
Published: (2022-12-01)

Ninetieth Anniversary of Parkinson’s Disease «Substantia Nigra» Theory
by: O.N. Voskresenskaya, et al.
Published: (2009-06-01)

Parkinson's disease: Cell Vulnerability and Disease Progression
by: Javier eBlesa, et al.
Published: (2015-09-01)

Luminopsins integrate opto- and chemogenetics by using physical and biological light sources for opsin activation
by: Berglund, Ken, et al.
Published: (2016)

Impact of region of interest size on transcranial sonography based computer-aided diagnosis for Parkinson’s disease
by: Xiaoyan Fei, et al.
Published: (2019-06-01)

A machine learning-based classification approach on Parkinson’s disease diffusion tensor imaging datasets
by: Jannik Prasuhn, et al.
Published: (2020-11-01)

Automated Assessment of the Substantia Nigra Pars Compacta in Parkinson’s Disease: A Diffusion Tensor Imaging Study
by: Niels Bergsland, et al.
Published: (2021-11-01)

Parkin promotes proteasomal degradation of p62: implication of selective vulnerability of neuronal cells in the pathogenesis of Parkinson’s disease
by: Pingping Song, et al.
Published: (2016-01-01)

EL NÚCLEO PEDUNCULOPONTINO Y SU RELACIÓN CON LA FISIOPATOLOGÍA DE LA ENFERMEDAD DE PARKINSON
by: LISETTE BLANCO LEZCANO, et al.
Published: (2012-09-01)

Amiloride is neuroprotective in an MPTP model of Parkinson's disease
by: Robert L. Arias, et al.
Published: (2008-09-01)

Sex differences for clinical correlates of substantia nigra neuron loss in people with Lewy body pathology
by: Ece Bayram, et al.
Published: (2024-01-01)

Local iron deficiency in the substantia nigra directly contributes to hyperlocomotion phenotypes
by: Zhuo Wang, et al.
Published: (2022-06-01)

Hypoxic-ischemic injury decreases anxiety-like behavior in rats when associated with loss of tyrosine-hydroxylase immunoreactive neurons of the substantia nigra
by: Hei Ming-Yan, et al.
Published: (2012-01-01)